The Federal Supply Schedule contract award to Moderna US, Inc. by the Department of Veterans Affairs Veterans Health Administration is valued at $225,000 and has a period of performance from January 1, 2024 to December 31, 2028. This multiple award contract will allow Moderna to supply the VA with drugs, pharmaceuticals, and hematology-related products to support Veteran healthcare services.
Moderna has also received several other major federal contract awards to provide COVID-19 mRNA vaccines, including a $7.8 billion firm fixed price contract from the Department of Health and Human Services and a $7.8 billion contract from the Department of the Army. These contracts, along with a $601 million indefinite delivery contract with the Centers for Disease Control and Prevention for pediatric COVID-19 vaccines and a $400 million contract for adult COVID-19 vaccines, demonstrate Moderna's role as a key supplier of critical pandemic response products to the federal government.
Generated 2/12/25, 9:09 AM